Startup profile · funding coverage

Vedana Therapeutics

Canaan Partners led a Series A for Vedana Therapeutics, extending the firm’s healthcare franchise as it deploys its $850M Fund XIII.

Stage

series a

Status

private

Coverage

full

Why Vedana Therapeutics is interesting

Vedana reflects Canaan Partners' long-standing healthcare practice (Day One Biopharmaceuticals, IDEAYA, Synthekine) alongside its technology investing, all from the same multi-generation platform. Canaan Partners led a Series A for Vedana Therapeutics, extending the firm’s healthcare franchise as it deploys its $850M Fund XIII.

Key facts

Disclosed financing: $850M (Series A)
Covered in 1 Venture Capital Tracker article(s)

Investors in our directory

Funds linked from Vedana Therapeutics's profile — open a fund page for stage focus and related deal articles.

Canaan Partners

Industries

Biotech & Life Sciences

Industry hub pages are rolling out from our fund-derived baseline taxonomy.